Therapy Areas: Autoimmune
18 May 2022 - - US-based clinical-stage neonatology and rare disease therapeutics company Oak Hill Bio has appointed Tauhid Ali, Ph.D. as the company's first chief executive officer, the company ...
17 May 2022 - US-based biopharmaceutical company AbbVie (NYSE: ABBV) and Cugene Inc., a US-based clinical-stage biotechnology company focused on developing next-generation precision immunology and onc...
16 May 2022 - Clinical stage oncology drug company Avacta Group plc (AIM:AVCT) reported on Monday that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded it...
13 May 2022 - - US-based biologic therapeutics developer Akston Biosciences Corp has dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as ...
11 May 2022 - - US-based biotechnology company Glyscend Therapeutics has completed a Phase 1 trial for its lead clinical-stage program, GLY-200, as a treatment for type 2 diabetes, the company said.
Related Headlines